Hold control (command on a Mac) and press the + key as many times as necessary to increase the font size.
Hold control (command on a Mac) and press the - key to reduce the font size. - hide

#1 Jan. 21, 2020 13:22:37

Kimberly
Online Facilitator
Registered: 2008-10-14
Posts: 4149
Profile  

FDA Approves Tepezza (teprotumumab-trbw)

The FDA has approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease. Wiley Chambers, M.D., deputy director of the Division of Transplant and Ophthalmology Products in the FDA’s Center for Drug Evaluation and Research noted, “Today’s approval marks an important milestone for the treatment of thyroid eye disease. Currently, there are very limited treatment options for this potentially debilitating disease. This treatment has the potential to alter the course of the disease, potentially sparing patients from needing multiple invasive surgeries by providing an alternative, non surgical treatment option.” Read more from the FDA regarding research results, adverse reactions, and the FDA's review process:

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-thyroid-eye-disease


Kimberly
GDATF Forum Facilitator

…through nature's inflexible grace, I'm learning to live…
– Dream Theater

Offline

#2 Jan. 22, 2020 12:52:11

Kimberly
Online Facilitator
Registered: 2008-10-14
Posts: 4149
Profile  

FDA Approves Tepezza (teprotumumab-trbw)



Kimberly
GDATF Forum Facilitator

…through nature's inflexible grace, I'm learning to live…
– Dream Theater

Offline

  • Root
  • » GDATF
  • » FDA Approves Tepezza (teprotumumab-trbw) [RSS Feed]

Board footer

Moderator control

Questions? Problems? Please contact us at [email protected] or 877-643-3123.

GDATF on Facebook

Support the GDATF and become a member today!

© 2020 Graves' Disease & Thyroid Foundation